0001754195-26-000032
SEC filingQ1 revenue declined 3.7% to $286.8M amid retail softening, yet profitability strengthened with operating income up 7.2% to $35.7M and net income turning positive at $2.3M, reflecting cost discipline and favorable tax dynamics.
Trulieve delivered mixed Q1 results with revenue of $286.8 million, down 3.7% from $297.8 million in the prior year. This decline stemmed from a decrease in retail revenue, partially offset by growth in wholesale and other revenue, as noted in management's discussion. Despite softer top-line performance, gross profit reached $170.1 million, representing a 59.3% margin—though down 7.2% year-over-year from $183.2 million. Management highlights that gross margins inherently fluctuate quarter-to-quarter based on product and market mix, inventory sell-through rates, promotional activity, and idle capacity costs, providing context for the compression observed this period.
Operating income improved to $35.7 million, a 7.2% increase from $33.3 million, yielding a 12.5% operating margin. This resilience underscores effective cost management, enabling leverage even as revenue softened. The swing to net income of $2.3 million—from a $33.8 million loss last year (106.8% YoY improvement)—reflects favorable changes in tax dynamics, positioning the company for sustained profitability.
Cash generation remains robust, with net cash provided by operating activities rising to $55.7 million from $50.7 million. Working capital primarily supports personnel expenses and costs tied to cultivation, processing, and distribution. Capital expenditures focus on expanding cultivation and processing facilities, retail dispensaries, and existing site improvements to fuel long-term growth, particularly in markets nearing adult-use catalysts, alongside technology infrastructure. The company anticipates continued cash from operations, bolstering its capacity to navigate competitive pressures as consumer bases potentially expand, intensifying product diversification and price competition.